Investor mix
5 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 60% |
| Bank & private debt | 1 | 20% |
| Other / undisclosed | 1 | 20% |
Protein therapeutics for inflammatory diseases such as systemic lupus erythematosus and multiple myeloma.
5 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 60% |
| Bank & private debt | 1 | 20% |
| Other / undisclosed | 1 | 20% |